Advisory Board

Webinar

CV market trends, part 2: Modernizing CV care teams and delivery

About the webinar

In the second part of this cardiovascular (CV) market trends series, Advisory Board will explore how CV leaders are modernizing care teams in response to market changes. We’ll discuss how health systems are reevaluating their CV ambulatory strategy and the expansion of non-physician roles in CV care. Finally, structural heart leaders will join us to discuss how their programs are responding to new transcatheter aortic valve replacement (TAVR) procedure requirements.

Things you'll learn:

  • How programs are leveraging advanced practice providers (APPs) to improve access and efficiency
  • How to start your own ambulatory surgery center (ASC) strategy
  • How different structural heart programs are responding to TAVR policy changes


 

You must register to join the session or access the materials or recording.

SPONSORED BY

Edwards logo

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, critical care, and surgical monitoring. Driven by a passion to help patients, Edwards partners with clinicians and healthcare stakeholders to improve outcomes and enhance lives through innovative technologies, evidence, and education

Speakers

Take a look at our speakers scheduled for this event

Rachael Peroutky

Research consultant, Pharmacy and diagnostics
Advisory Board

Registration

* 

What's your primary purpose for participating in this event?

This question is required.

Sponsors may contact you after the event to share resources or get in touch.

* 

By clicking submit below I agree and consent to Advisory Board collecting, using, processing, and storing my personal information including my name and email so that Advisory Board may contact me in relation to the services that I receive from Advisory Board. I acknowledge that my personal data will be stored within the United States of America which may not provide the same level of protection as my home country. This consent is valid unless I have opted out or withdrawn consent. I understand that consent may be withdrawn at any time by contacting Optum at information_governance@optum.com. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

Advisory Board